Youngevity International launches advanced anti-aging supplement

NewsGuard 100/100 Score

Youngevity International, Inc. (OTCQX: YGYI) (www.YGYI.com), a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channels, announces the launch of an advanced anti-aging supplement, Imortalium™ into our global direct sales channel.

Imortalium™ combines the most effective anti-aging nutrients in a cutting-edge, bi-layered and extended release tablet that nutritionally helps promote cellular longevity and telomere health to help slow the natural aging process. Imortalium™ contains synergizing antioxidant enzymes and essential nutrients that offer among the greatest telomere support.

In order to further advance the anti-aging qualities of Imortalium™, it has been packaged in a unique, technologically advanced Miron violet glass bottle. The Miron violet glass works as a filter that blocks the complete spectrum of visible light with the exception of the violet wave length to protect the quality of the nutrients in each tablet.

William Andreoli, President of Youngevity International said, "The global anti-aging product market is growing and expected to reach over $290 billion by 2015, which is fuelled by the aging population seeking anti-aging support in the form of nutritional supplementation. The importance of telomeres to health and ageing continues to grow. The discovery of telomeres and how they protect the ends of chromosomes against degradation had a major impact within the scientific community and a team of scientists were awarded a Noble Prize in Physiology of Medicine in 2009. Youngevity is dedicated to delivering solutions to help health-conscious people Live Younger, Longer and we believe Imortalium is a solution for healthy aging."

"We received a very enthusiastic response from our global distributor and customer base during the launch of our new breakthrough anti-aging supplement, Imortalium, on December 31st," said Steve Wallach, Youngevity's Chief Executive Officer. "We are very excited about the tremendous potential benefits and results of Imortalium to combat aging and believe we have a great opportunity to make a major impact in the growing multi-billion dollar anti-aging global product market. We filed a trademark for the name Imortalium through the U.S. Patent and Trademark Office (USPTO) in January 2013 and we anticipate the registration of the trademark early this year."

"Our New Year's Eve conference call was a huge success and a great way to start the year for our growing Company," said Dave Briskie, Chief Financial Officer of Youngevity International. "We made other major announcements during the call, which included the introduction of our Youngevity 90 for Life mobile app to bring our sales platform into the mobile world of smartphones and tablets. We also introduced our multi-vitamin/mineral complex on-the-go Beyond Tangy Tangerine 2.0 Stick Packs and Beyond Hot Chocolate made from organic cacao beans. We will continue to accelerate our expansion into various international markets and expect this will be a major growth driver for the next several years."

SOURCE Youngevity International Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Penn State study examines how a person's telomeres are affected by caloric restriction